Doxorubicin-loading core-shell pectin nanocell: A novel nanovehicle for anticancer agent delivery with multidrug resistance reversal

Tumor is a prevalent great threat to public health worldwide and multidrug resistance (MDR) of tumor is a leading cause of chemotherapy failure. Nanomedicine has shown prospects in overcoming the problem. Doxorubicin (DOX), a broad-spectrum anticancer drug, showed limited efficacy due to MDR. Herein...

Descripción completa

Detalles Bibliográficos
Autores principales: Ouyang, Jiabi, Yang, Mohui, Gong, Tian, Ou, Jinlai, Tan, Yani, Zhang, Zhen, Li, Sha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307773/
https://www.ncbi.nlm.nih.gov/pubmed/32569270
http://dx.doi.org/10.1371/journal.pone.0235090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307773/
https://www.ncbi.nlm.nih.gov/pubmed/32569270
http://dx.doi.org/10.1371/journal.pone.0235090

Ejemplares similares